WebNews
Please enter a web search for web results.
NewsWeb
France becomes first EU country to reimburse anti-obesity drugs, minister says
2+ hour, 15+ min ago (421+ words) May 28 (Reuters) - France will reimburse the cost of weight-loss drugs prescribed toseverely obese "patients from mid-June in a first for a European Union country, Health "Minister Stephanie Rist said on Thursday. Novo Nordisk's Wegovy and Eli Lilly's Mounjaro medications have…...
Lilly to present new data on Foundayo, Mounjaro and retatrutide at the American Diabetes Association's 86th Scientific Sessions, building toward a new era of choice in diabetes and obesity care
15+ min ago (1287+ words) May 28, 2026, 13: 00 ET Phase 3 ACHIEVE results showed Foundayo, an oral GLP-1 taken without food or water restrictions, outperformed oral semaglutide and dapagliflozin in type 2 diabetes, reinforcing its potential to redefine oral incretin therapy New analyses of the ATTAIN program highlight Foundayo's…...
Beer Belly or Silent Killer? New Research Links Visceral Fat to a Higher Risk of Heart Attacks - AOL
2+ day, 23+ hour ago (111+ words) What changes feel most realistic for reducing visceral fat in everyday life, and which habits seem the hardest to break? Hidden Sugars in "Healthy" Energy Drinks Are Destroying Men's Teeth " Dentists Warn of Acid Erosion 7 "Healthy" Comfort Foods That Are…...
Warning over online pharmacies claiming to be linked to Grimsby's hospital
5+ hour, 17+ min ago (202+ words) Grimsby Live NHS Humber Health Partnership said 'we do not operate any online pharmaceutical companies, even if they are claiming to be based at our hospitals' "We're concerned people are parting with their money for medicines that do not appear,…...
MTVA: No Evidence for Changes in Cardiovascular Parameters in Phase 1 Trial of DA-1726
2+ hour, 22+ min ago (150+ words) READ THE FULL MTVA RESEARCH REPORT Treatment with DA-1726 Shows No Evidence of Cardiovascular Changes Thus far, DA-1726 has had a favorable tolerability profile, as shown in the following table. Gastrointestinal adverse events (AEs) have been mostly mild-to-moderate in severity…...
Rapid Weight Loss Can Permanently Damage Your Metabolism
2+ hour, 23+ min ago (669+ words) New Delhi: The growing obsession with rapid weight loss and dramatic body transformations is pushing many people towards extreme crash diets that promise quick results within days. But health experts warn that losing weight too fast may permanently damage the…...
New oral GLP-1s encourage patients to switch from compounded versions
50+ min ago (461+ words) "I have patients increasingly coming to me saying, 'I hear it's not as expensive to get the pharmaceutical-grade branded version, can we switch over?'" said Dr. Michael Weintraub, assistant clinical professor of endocrinology at NYU Langone in New York. Some…...
SURPASS-CVOT: Tirzepatide Significantly Reduces Major Kidney Events Compared to Dulaglutide in T2 D
1+ hour ago (330+ words) SURPASS-CVOT Trial Shows Tirzepatide Significantly Reduces Major Kidney Events Compared to Dulaglutide in Type 2 Diabetes A study published in The Lancet Diabetes & Endocrinology found that tirzepatide, a first-in-class dual agonist targeting the glucose-dependent insulinotropic polypeptide (GIP) receptor and the GLP…...
Excitement and interest as Lp(a) therapies inch closer
59+ min ago (626+ words) Late-phase trials of targeted therapies for elevated lipoprotein(a) are nearing completion, with the first readouts expected later this year....
Long-term AD Impacts Educational and Career Choices
1+ hour, 57+ min ago (587+ words) Adults with AD, particularly those with childhood onset, report significantly greater limitations in their educational and professional choices, with up to 38% of childhood-onset patients reporting career restrictions and more than 36% reporting constrained study choices, compared to individuals whose disease began…...